Beta-thalassemia
Open accessThe DOI matches its Crossref record; 4 of the 89 references it cites were found in a registry or an index, and 85 are not checked yet.
Abstract
Beta-thalassemia is caused by the reduced (beta) or absent (beta) synthesis of the beta globin chains of the hemoglobin tetramer. Three clinical and hematological conditions of increasing severity are recognized, i.e., the beta-thalassemia carrier state, thalassemia intermedia, and thalassemia major. The beta-thalassemia carrier state, which results from heterozygosity for beta-thalassemia, is clinically asymptomatic and is defined by specific hematological features. Thalassemia major is a severe transfusion-dependent anemia. Thalassemia intermedia comprehend a clinically and genotypically very heterogeneous group of thalassemia-like disorders, ranging in severity from the asymptomatic carrier state to the severe transfusion-dependent type. The clinical severity of beta-thalassemia is related to the extent of imbalance between the alpha and nonalpha globin chains. The beta globin (HBB) gene maps in the short arm of chromosome 11, in a region containing also the delta globin gene, the embryonic epsilon gene, the fetal A-gamma and G-gamma genes, and a pseudogene (psiB1). Beta-thalassemias are heterogeneous at the molecular level. More than 200 disease-causing mutations have been so far identified. The majority of mutations are single nucleotide substitutions, deletions, or insertions of oligonucleotides leading to frameshift. Rarely, beta-thalassemia results from gross gene deletion. In addition to the variation of the phenotype resulting from allelic heterogeneity at the beta globin locus, the phenotype of beta-thalassemia could also be modified by the action of genetic factors mapping outside the globin gene cluster and not influencing the fetal hemoglobin. Among these factors, the ones best delineated so far are those affecting bilirubin, iron, and bone metabolisms. Because of the high carrier rate for HBB mutations in certain populations and the availability of genetic counseling and prenatal diagnosis, population screening is ongoing in several at-risk populations in the Mediterranean. Population screening associated with genetic counseling was extremely useful by allowing couples at risk to make informed decision on their reproductive choices. Clinical management of thalassemia major consists in regular long-life red blood cell transfusions and iron chelation therapy to remove iron introduced in excess with transfusions. At present, the only definitive cure is bone marrow transplantation. Therapies under investigation are the induction of fetal hemoglobin with pharmacologic compounds and stem cell gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,169
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Research works printed but not linked: 5
- Wheatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford, England: Blackwell Science Ltd, 2001.
- Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Beaudet Al, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease (OMMBID). Chapter 101. New York, NY: McGraw-Hill, 2002. Available at: www.ommbid.com. Accessed December 31, 2007.
- Rees, 1998, Genetic influenes on bone disease in thalassemia, Blood, 92, S532a
- Dresner Pollak, 2000, Bone mineral metabolism in adults with beta thalassemia major and intermedia, Br J Haematol, 111, 902
- Galanello, 1990, Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosome, Blood, 15, 75:11747
Cited by
Items 701–721 of 721
Constituents of Blood: Functions and Disorders
Dash, H. R., Al-Snan, N. R., & Messaoudi, S. A. (2026) · Springer eBooks · doi:10.1007/978-981-95-9183-1_2
Alesufi, A., Lehyah, N. A. A. A., Nasrieh, D. A., Banihani, H. A., Aburumman, S., Zibara, Z., Fakih, N., Al-Karmi, L., Nawaiseh, M. A., & Shersheer, Q. A. (2026) · Medicine · doi:10.1097/md.0000000000048717
Chowdhury, T. D., Shafoyat, M. U., Haque, S. R., Islam, M. T., Hasan, M., Majib, M. S., Rahman, M. M., Siddiquee, K. N. E. A., Mannoor, K., & Islam, M. S. (2026) · Research Square · doi:10.21203/rs.3.rs-9299039/v1
Preechathaveekid, S., Rungjirajittranon, T., Chanpo, N., Dujjawan, B., & Hantaweepant, C. (2026) · Hemoglobin · doi:10.1080/03630269.2026.2684611
Genetic Mutations and Clinical Severity in Hemoglobin E/Beta-Thalassemia Patients in Bangladesh
Mahzabin, N., Islam, I. A., Dey, M., Chowdhury, M. R. R., Sajib, M. K. H., Aziz, M. A., Jishan, T. R., & Kabir, P. D. A. L. (2026) · Cureus · doi:10.7759/cureus.111264
Abed, N. K. (2026) · European journal of ecology, biology and agriculture. · doi:10.59324/ejeba.2026.3(3).25
Ali, N. T., Abdullah, R. S., Mehdi, M. A. H., Ali, G. S., Ali, H. M., Gubran, A. N. M., & Al-Abd, N. (2026) · Human Mutation · doi:10.1155/humu/9405486
Marone, R., Lepore, R., Paschoudi, K., Zuin, J., Sinopoli, A., Camus, A., Burgold, T., Bartoszek, E. M., Calabrese, D., Toranelli, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.07.736903
Adhiyanto, C., Zaki, A., Sari, G. P., Ferania, M., Mimanda, Y., Hendarmin, L. A., Suryani, S., Puspitaningrum, R., Latifah, A., Pornprasert, S., et al. (2026) · Thalassemia Reports · doi:10.3390/thalassrep16030015
Genotype’s Role in Beta Thalassemia: From DNA to DiseasePreprint
Bhowad, S. (2026) · Research Square · doi:10.21203/rs.3.rs-10389283/v1
Mohammed, S. J., Bdaiwi, Y. F., Tawfeeq, M. M., Alhatem, Z., Dawad, M. M., & Alshewered, A. (2026) · Гематология Трансфузиология Восточная Европа · doi:10.34883/pi.2026.12.1.013
Pushkala, S., Srilakshmi, S., Valarmathi, S., Sivaranjani, E., & Veeralakshmi, M. (2026) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20262632
Fairooz, H. A., Abdelhédi, R., Khalil, S. H., Kharrat, N., & Hmani, M. (2026) · Genes · doi:10.3390/genes17080906 · Cited by 1
Alghamdi, M. A., Almalki, S. A., Bahieldin, A., Radhwi, O., & Rather, I. A. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1853312
Evaluation of Renal Function Biomarkers in Yemeni Patients with Transfusion-Dependent β-Thalassemia
Al-absi, B., Qateena, E., Anam, N., Noman, R., AL-shmahi, R., & AL-asbahi, A. (2026) · Ar-Rasheed University Journal of Basic and Applied Sciences · doi:10.67151/rujbas.v1i1.25
An Integrated Gene Therapy Strategy for γ-Globin Addition and HbF Reactivation in β-Thalassemia
Paschoudi, K., Vasiloudis, N.-I., Papadopoulos, F., Nikolaou, X., Παπαδοπούλου, Α., Sova, P., Yannaki, E., & Psatha, N. (2026) · Thalassemia Reports · doi:10.3390/thalassrep16030019
Ast, D., Ribeiro, R., Gosch, A., Preuß-Wössner, J., Rothschild, M. A., Ferreira, P. G., Courts, C., & Gomes, I. (2026) · Forensic Science International Genetics · doi:10.1016/j.fsigen.2026.103616
Ullah, J., & Musharraf, S. G. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119901
Awareness of β-Thalassemia Among Non-Medical Students in UAE
Khan, S., Parveen, Y., Mamtaz, S., Patel, A., & Nosseir, N. (2026) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/26aug879
Khin, C. K., Ruengdit, C., Punyamung, M., & Pornprasert, S. (2026) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-026-02622-1
Harnathka, G., Saini, S., Sah, R. P., Tendulkar, P., & Kant, R. (2026) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20264209
Metadata
- Authors
- Cao, A., & Galanello, R.
- Affiliations
- National Research Council (IT)
- University of Cagliari (IT)
- Corresponding author
- Cao, Antonio
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 12
- Issue
- 2
- Pages
- 61-76
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W4210970197
- Cited by
- 722
- References
- 4
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 63 · 2023: 61 · 2022: 60 · 2021: 66 · 2020: 69 · 2019: 64 · 2018: 48 · 2017: 58 · 2016: 52 · 2015: 24 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4370 d)
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- beta-thalassemia, beta-globin gene, HBB mutations, thalassemia major, thalassemia intermedia, transfusion-dependent anemia, iron chelation therapy, bone marrow transplantation, fetal hemoglobin induction, genetic counseling, prenatal diagnosis, chromosome 11
- MeSH terms
- Female, Multigene Family, Genetic Testing, Globins, Genetic Carrier Screening, Humans, Pregnancy, Prenatal Diagnosis, Bone Marrow Transplantation, beta-Thalassemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.